Rallybio Corp. (RLYB)
17.03
+0.16
(+0.92%)
USD |
NASDAQ |
Sep 14, 10:32
Rallybio Price : 17.03 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 16.75 | 16.88 | 16.70 | 16.88 | 6627.00 |
| Sep 10, 2026 | 16.80 | 17.06 | 16.71 | 16.75 | 6142.00 |
| Sep 09, 2026 | 16.52 | 17.05 | 16.50 | 16.97 | 9033.00 |
| Sep 08, 2026 | 16.97 | 16.97 | 16.61 | 16.61 | 7026.00 |
| Sep 04, 2026 | 16.75 | 17.01 | 16.75 | 16.92 | 4180.00 |
| Sep 03, 2026 | 16.66 | 17.09 | 16.66 | 16.88 | 2508.00 |
| Sep 02, 2026 | 16.65 | 17.26 | 16.65 | 16.94 | 29840.00 |
| Sep 01, 2026 | 17.05 | 17.05 | 16.67 | 16.69 | 11182.00 |
| Aug 31, 2026 | 16.68 | 17.05 | 16.50 | 16.79 | 14139.00 |
| Aug 28, 2026 | 16.51 | 17.12 | 16.51 | 16.81 | 5762.00 |
| Aug 27, 2026 | 17.18 | 17.23 | 16.76 | 16.76 | 5880.00 |
| Aug 26, 2026 | 16.95 | 17.03 | 16.75 | 16.88 | 3697.00 |
| Aug 25, 2026 | 16.81 | 17.03 | 16.64 | 16.88 | 7445.00 |
| Aug 24, 2026 | 16.54 | 16.86 | 16.54 | 16.80 | 6681.00 |
| Aug 21, 2026 | 16.76 | 16.95 | 16.55 | 16.83 | 6869.00 |
| Aug 20, 2026 | 16.78 | 16.98 | 16.51 | 16.60 | 15283.00 |
| Aug 19, 2026 | 17.12 | 17.20 | 16.86 | 17.00 | 17779.00 |
| Aug 18, 2026 | 16.87 | 17.14 | 16.73 | 16.77 | 10257.00 |
| Aug 17, 2026 | 17.00 | 17.29 | 16.66 | 17.00 | 17128.00 |
| Aug 14, 2026 | 17.01 | 17.23 | 16.67 | 16.99 | 12923.00 |
| Aug 13, 2026 | 16.75 | 17.35 | 16.75 | 16.96 | 74312.00 |
| Aug 12, 2026 | 16.39 | 16.80 | 16.33 | 16.59 | 17665.00 |
| Aug 11, 2026 | 16.81 | 16.81 | 16.34 | 16.38 | 8781.00 |
| Aug 10, 2026 | 16.25 | 16.98 | 16.23 | 16.61 | 23320.00 |
| Aug 07, 2026 | 16.11 | 16.51 | 16.02 | 16.16 | 12303.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Beam Therapeutics, Inc. | 24.32 |
| C4 Therapeutics, Inc. | 3.47 |
| Cullinan Therapeutics, Inc. | 19.80 |
| Q32 Bio, Inc. | 10.92 |
| Arrowhead Pharmaceuticals, Inc. | 81.70 |
Price Related Metrics
| PE Ratio | 2.180 |
| PS Ratio | 147.64 |
| Price to Book Value | 0.9564 |
| Price to Free Cash Flow | 3.571 |
| Earnings Yield | 45.87% |
| Market Cap | 90.38M |
| Normalized PE Ratio | 6.870 |